Clinical Trials

348 enrolled

Uterine Cervical Neoplasms

NCT05827523 2026-02-13

FOCUS / KOV-04

Phase 3 Recruiting

520 enrolled

Phase 3 Active not recruiting

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT05316181 2026-02-12

KOV-HIPEC-02R

140 enrolled

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT01279135 2026-02-06

PARCER

300 enrolled

Uterine Cervical Neoplasms

NCT07164534 2026-02-04

CHOC-LATE

316 enrolled

Uterine Cervical Neoplasms

NCT04073706 2026-01-30

ENDO-3

Phase 3 Recruiting

760 enrolled

Uterine Neoplasms, Endometrial Neoplasms

NCT07068464 2025-07-16

ICRA

682 enrolled

Ovarian Neoplasms

NCT02446652 2025-05-29

Evaluation of TRANSKRIP ® Plus Chemotherapy in Recurrent-Persistent Cervical Cancer

Phase 3 Withdrawn

Uterine Cervical Neoplasms

NCT06156514 2025-05-28

MICHELE

Phase 3 Recruiting

140 enrolled

Phase 3 Active not recruiting

Locally Advanced Cervical Cancer

NCT02859038 2025-02-10

Study of Upfront Surgery Versus Neoadjuvant Chemotherapy in Patients With Advanced Ovarian Cancer (SUNNY)

489 enrolled

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

NCT06542549 2024-08-07

Efficacy and Safety of AK104 (PD-1/CTLA-4 Bispecial Antibody) Combined With Chemotherapy for Neoadjuvant Treatment of Advanced Ovarian Cancer

100 enrolled

Advanced Ovarian Cancer

NCT06539091 2024-08-06

Fluzoparib in Combination With Apatinib Mesylate for Maintenance Therapy in Stage III-IV Ovarian Cancer

51 enrolled

Carcinoma, Ovarian Epithelial

NCT01611766 2021-06-10

Surgery or Chemotherapy in Recurrent Ovarian Cancer (SOC 1 Trial)?

356 enrolled

Fallopian Tube Neoplasms, Ovarian Neoplasms, Recurrence

NCT04515602 2020-08-27

FOCUS

410 enrolled

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

NCT00193739 2019-09-20

NACTcervix

635 enrolled

Uterine Cervical Neoplasms

NCT00096408 2019-03-20

Laparoscopic Approach to Cancer of the Endometrium

760 enrolled

Adenocarcinoma, Carcinoma, Neoplasms, Endometrial Neoplasms

NCT03162276 2018-09-07

Trial of Inquiry Based Stress Reduction (IBSR) Program for BRCA1/2 Mutation Carriers

118 enrolled

BreastGynecologic

Hereditary Breast and Ovarian Cancer Syndrome

NCT02957266 2016-11-15

CERVIPIB

400 enrolled

Uterine Cervical Neoplasms

NCT00532194 2015-09-23

ICON6

486 enrolled

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00193830 2015-05-06

High Dose Rate (HDR) Versus Low Dose Rate (LDR) Brachytherapy in Carcinoma Cervix

750 enrolled

Barakat syndrome, Uterine Cervical Neoplasms

NCT02083211 2015-04-14

Combination of Nimotuzumab Cisplatin-Vinorelbine in First Line Chemotherapy in Recurring-Persistent Cervical Carcinoma

168 enrolled

Uterine Cervical Neoplasms, Recurrence

NCT00850772 2014-06-12

OPEN

109 enrolled

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms, Malnutrition

NCT01654146 2012-07-31

ICON8

1,485 enrolled

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT01288599 2012-07-03

Single Versus Conventional Laparoscopy for Benign Adnexal Disease

40 enrolled

Adnexal Diseases, Ovarian Cysts

NCT00122772 2011-10-14

CRP on Radiobiological and Clinical Studies on Viral-Induced Cancer's Response to Radiotherapy

601 enrolled

Uterine Cervical Neoplasms

NCT00122746 2011-10-13

Clinical and Experimental Studies to Improve Radiotherapy Outcome in AIDS Cancer Patients

322 enrolled

Acquired Immunodeficiency Syndrome, Uterine Cervical Neoplasms

NCT00532818 2009-03-30

Hydralazine Valproate for Cervical Cancer

143 enrolled

Uterine Cervical Neoplasms

NCT00533299 2007-09-21

Hydralazine Valproate for Ovarian Cancer

211 enrolled